A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer.
Saved in:
| Title: | A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer. |
|---|---|
| Authors: | Falkson CI; Department of Medical Oncology, University of Pretoria, South Africa., Falkson HC |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1996 Jul; Vol. 7 (5), pp. 465-9. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Print ISSN: 0923-7534 (Print) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
